Xponance LLC’s Abbvie Inc Position
Does Xponance LLC own Abbvie Inc (ABBV)? Yes — 511.9K shares worth $111M (+0.79% of its 13F portfolio) as of Q1 2026, up from 479.6K shares the prior filed quarter.
Position Value
$111M
Q1 2026
Shares
511.9K
% of Portfolio
+0.79%
Quarters Held
24
currently held
Position History ABBV
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 511.9K | $111M | +0.79% |
| Q4 2025 | 479.6K | $110M | +0.82% |
| Q3 2025 | 463.7K | $107M | +0.85% |
| Q2 2025 | 451.3K | $84M | +0.70% |
| Q1 2025 | 343.5K | $72M | +0.70% |
| Q4 2024 | 338.9K | $60M | +0.55% |
| Q3 2024 | 339.5K | $67M | +0.65% |
| Q2 2024 | 332.6K | $57M | +0.58% |
| Q1 2024 | 419.4K | $76M | +0.80% |
| Q4 2023 | 412.6K | $64M | +0.77% |
| Q3 2023 | 405.6K | $60M | +0.82% |
| Q2 2023 | 402.5K | $54M | +0.72% |
| Q1 2023 | 397.5K | $63M | +0.93% |
| Q4 2022 | 389.5K | $63M | +1.02% |
| Q3 2022 | 355.1K | $48M | +0.92% |
| Q2 2022 | 329.6K | $50M | +1.01% |
| Q1 2022 | 338.2K | $55M | +0.91% |
| Q4 2021 | 309.3K | $42M | +0.66% |
| Q3 2021 | 285.2K | $31M | +0.58% |
| Q2 2021 | 335.5K | $38M | +0.69% |
| Q1 2021 | 325.1K | $35M | +0.75% |
| Q4 2020 | 325.2K | $35M | +0.76% |
| Q3 2020 | 323.5K | $28M | +0.70% |
| Q2 2020 | 340.7K | $33M | +0.86% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Xponance LLC’s full portfolio or all institutional holders of ABBV.